PUBLISHER: Persistence Market Research | PRODUCT CODE: 1747235

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1747235

Liquid Embolic Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

PUBLISHED: June 11, 2025

PAGES: 200 Pages

DELIVERY TIME: 2-5 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for liquid embolic agents. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global liquid embolic market from 2025 to 2032.

Key Insights:

Liquid Embolic Market Size (2025E): USD 384.2 Million
Projected Market Value (2032F): USD 703.6 Million
Global Market Growth Rate (CAGR 2025 to 2032): 9.0%

Liquid Embolic Market - Report Scope:

Liquid embolic agents are specialized medical materials used to occlude blood vessels and treat vascular abnormalities such as arteriovenous malformations (AVMs), aneurysms, and tumors. These agents include polymers, copolymers, and other biocompatible substances that solidify or precipitate within vessels to block blood flow and prevent hemorrhages or abnormal blood circulation. The liquid embolic market serves hospitals, interventional radiology centers, and neurosurgical clinics, offering a variety of embolic products such as Onyx, PHIL, and others. Market growth is driven by increasing prevalence of cerebrovascular and peripheral vascular diseases, rising demand for minimally invasive procedures, and advancements in embolic materials enhancing safety and efficacy.

Market Growth Drivers:

The global liquid embolic market is propelled by several key factors, including growing awareness and adoption of minimally invasive endovascular therapies for managing vascular disorders. The increasing incidence of brain aneurysms, AVMs, and peripheral artery diseases, along with rising geriatric populations prone to vascular complications, further fuels demand. Technological innovations in liquid embolic compositions, such as improved polymer formulations and radiopacity, enhance procedural precision and patient outcomes. Additionally, expanding healthcare infrastructure in emerging economies and favorable reimbursement policies support market expansion. The trend toward outpatient interventional procedures and increasing preference for embolization over surgical resection also contribute to market growth.

Market Restraints:

Despite promising growth prospects, the liquid embolic market faces challenges related to high treatment costs, limited skilled interventionists, and potential complications such as non-target embolization and allergic reactions. Regulatory hurdles concerning the approval of novel embolic materials can delay product launches and market entry. Moreover, lack of awareness among patients and healthcare providers about the benefits of liquid embolics, particularly in developing regions, constrains market penetration. Addressing these challenges requires increased training programs, streamlined regulatory pathways, and enhanced educational initiatives to promote wider adoption.

Market Opportunities:

The liquid embolic market presents significant growth opportunities driven by continuous research and development, expanding indications, and integration of advanced imaging techniques for better procedural accuracy. Emerging applications in oncology for tumor embolization and in treating gastrointestinal bleeding expand market scope. The development of biocompatible, biodegradable embolic agents with fewer side effects opens new avenues for innovation. Strategic collaborations between manufacturers, healthcare providers, and research institutions can accelerate product development and market outreach. Furthermore, growing healthcare expenditure and increasing investments in minimally invasive technologies create favorable conditions for market growth.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the liquid embolic market globally?
Which types of liquid embolic agents and clinical applications are driving adoption across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the liquid embolic market?
Who are the key players contributing to the liquid embolic market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global liquid embolic market?

Competitive Intelligence and Business Strategy:

These companies invest heavily in R&D to develop novel embolic materials with enhanced biocompatibility, visibility, and ease of delivery. Collaborations with healthcare institutions and training programs for interventional specialists aid in increasing adoption rates. Moreover, emphasis on clinical trials and regulatory approvals supports market credibility and drives growth in various geographies.

Key Companies Profiled:

Cerenovus (J&J)
Medtronic
Sirtex Medical Inc.
Terumo Neuro
Balt
Meril Life Sciences Pvt. Ltd
INVAMED
Peters Surgical

Liquid Embolic Market Research Segmentation:

The liquid embolic market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various vascular disorders and patient populations.

By Product

Liquid Embolic Vials
Prefilled Injectables

By Indication

Brain Arterio-Venous Malformations (bAVM)
Tumor Embolization
Brain Aneurysm
Dural Arteriovenous Fistulas (dAVFs)
Others

By End-user

Hospitals
Ambulatory Surgical Centers
Independent Speciality Centres
Others

By Region:

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East & Africa

Product Code: PMRREP25513

1. Executive Summary

1.1. Global Liquid Embolic Market Snapshot, 2025-2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Product Adoption Analysis
3.2. Disease Epidemiology - Neurology Disorders
3.3. Regulatory Landscape
3.4. PESTLE Analysis
3.5. Porter's Five Force Analysis
3.6. Promotional Strategies, By Key Players

4. Global Liquid Embolic Market Outlook

4.1. Key Highlights
- 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
4.3. Global Liquid Embolic Market Outlook: Product
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2024
- 4.3.3. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  - 4.3.3.1. Liquid Embolic Vials
  - 4.3.3.2. Prefilled Injectables
- 4.3.4. Market Attractiveness Analysis: Product
4.4. Global Liquid Embolic Market Outlook: Indication
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Mn), By Indication, 2019-2024
- 4.4.3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
  - 4.4.3.1. Brain Arterio-Venous Malformations (bAVM)
  - 4.4.3.2. Tumor Embolization
  - 4.4.3.3. Brain Aneurysm
  - 4.4.3.4. Dural Arteriovenous Fistulas (dAVFs)
  - 4.4.3.5. Others
- 4.4.4. Market Attractiveness Analysis: Indication
4.5. Global Liquid Embolic Market Outlook: End User
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Mn), By End User, 2019-2024
- 4.5.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  - 4.5.3.1. Hospitals
  - 4.5.3.2. Ambulatory Surgical Centers (ASCs)
  - 4.5.3.3. Independent Specialty Centers
  - 4.5.3.4. Others
- 4.5.4. Market Attractiveness Analysis: End User

5. Global Liquid Embolic Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
5.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Liquid Embolic Market Outlook

6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 6.2.1. By Country
- 6.2.2. By Product
- 6.2.3. By Indication
- 6.2.4. By End User
6.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 6.4.1. Liquid Embolic Vials
- 6.4.2. Prefilled Injectables
6.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 6.5.1. Brain Arterio-Venous Malformations (bAVM)
- 6.5.2. Tumor Embolization
- 6.5.3. Brain Aneurysm
- 6.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 6.5.5. Others
6.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 6.6.1. Hospitals
- 6.6.2. Ambulatory Surgical Centers (ASCs)
- 6.6.3. Independent Specialty Centers
- 6.6.4. Others
6.7. Market Attractiveness Analysis

7. Europe Liquid Embolic Market Outlook

7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Indication
- 7.2.4. By End User
7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
7.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 7.4.1. Liquid Embolic Vials
- 7.4.2. Prefilled Injectables
7.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 7.5.1. Brain Arterio-Venous Malformations (bAVM)
- 7.5.2. Tumor Embolization
- 7.5.3. Brain Aneurysm
- 7.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 7.5.5. Others
7.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 7.6.1. Hospitals
- 7.6.2. Ambulatory Surgical Centers (ASCs)
- 7.6.3. Independent Specialty Centers
- 7.6.4. Others
7.7. Market Attractiveness Analysis

8. East Asia Liquid Embolic Market Outlook

8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Indication
- 8.2.4. By End User
8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 8.4.1. Liquid Embolic Vials
- 8.4.2. Prefilled Injectables
8.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 8.5.1. Brain Arterio-Venous Malformations (bAVM)
- 8.5.2. Tumor Embolization
- 8.5.3. Brain Aneurysm
- 8.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 8.5.5. Others
8.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 8.6.1. Hospitals
- 8.6.2. Ambulatory Surgical Centers (ASCs)
- 8.6.3. Independent Specialty Centers
- 8.6.4. Others
8.7. Market Attractiveness Analysis

9. South Asia & Oceania Liquid Embolic Market Outlook

9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Indication
- 9.2.4. By End User
9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 9.4.1. Liquid Embolic Vials
- 9.4.2. Prefilled Injectables
9.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 9.5.1. Brain Arterio-Venous Malformations (bAVM)
- 9.5.2. Tumor Embolization
- 9.5.3. Brain Aneurysm
- 9.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 9.5.5. Others
9.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 9.6.1. Hospitals
- 9.6.2. Ambulatory Surgical Centers (ASCs)
- 9.6.3. Independent Specialty Centers
- 9.6.4. Others
9.7. Market Attractiveness Analysis

10. Latin America Liquid Embolic Market Outlook

10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Indication
- 10.2.4. By End User
10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 10.4.1. Liquid Embolic Vials
- 10.4.2. Prefilled Injectables
10.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 10.5.1. Brain Arterio-Venous Malformations (bAVM)
- 10.5.2. Tumor Embolization
- 10.5.3. Brain Aneurysm
- 10.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 10.5.5. Others
10.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 10.6.1. Hospitals
- 10.6.2. Ambulatory Surgical Centers (ASCs)
- 10.6.3. Independent Specialty Centers
- 10.6.4. Others
10.7. Market Attractiveness Analysis

11. Middle East & Africa Liquid Embolic Market Outlook

11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Indication
- 11.2.4. By End User
11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 11.4.1. Liquid Embolic Vials
- 11.4.2. Prefilled Injectables
11.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 11.5.1. Brain Arterio-Venous Malformations (bAVM)
- 11.5.2. Tumor Embolization
- 11.5.3. Brain Aneurysm
- 11.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 11.5.5. Others
11.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 11.6.1. Hospitals
- 11.6.2. Ambulatory Surgical Centers (ASCs)
- 11.6.3. Independent Specialty Centers
- 11.6.4. Others
11.7. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2025
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Cerenovus (J&J)
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Products
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. Medtronic
- 12.3.3. Sirtex Medical Inc.
- 12.3.4. Terumo Neuro
- 12.3.5. Balt
- 12.3.6. Meril Life Sciences Pvt. Ltd
- 12.3.7. INVAMED
- 12.3.8. Peters Surgical